AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
With a market cap of 298.6B, AstraZeneca(AZN) trades at $193.69. The stock has a price-to-earnings ratio of 29.11 and currently yields dividends of 1.6%.
On 2026-03-17, AstraZeneca(AZN) stock moved within a range of $193.62 to $194.10. With shares now at $193.69, the stock is trading +0.0% above its intraday low and -0.2% below the session's peak.
Trading volume for AstraZeneca(AZN) stock has reached 5.64K, versus its average volume of 2.01M.
The stock's 52-week range extends from a low of $122.48 to a high of $212.71.
The stock's 52-week range extends from a low of $122.48 to a high of $212.71.
AZN News
The company states: “AstraZeneca’s (AZN) Imfinzi, in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel)...
Imfinzi and chemotherapy is approved in the U.S. and applications are under review in countries including Japan. stefan wermuth/Reuters AstraZeneca AZN 0.11 %i...
Astrazeneca (AZN) closed the most recent trading day at $189.90, moving -1.35% from the previous trading session. The stock's performance was behind the S&P 500...
Analyst ratings
81%
of 31 ratingsMore AZN News
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study LYNPARZA Tablets 100mg, 150mg General Drug Use-results Study tracks how Astr...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. The DURGA-4 study, formally titled “A Phase III Open-label, Randomised, Multicent...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca study tracks how two versions of its asthma drug move through childre...
British drugmaker AstraZeneca Plc (NYSE:AZN) has emerged as the leading contender to acquire French biotech Abivax SA (NASDAQ:ABVX) , following the company's dr...
05:45 EDT Abivax (ABVX) jumps 15% to $129.11 after report of exclusivity with AstraZeneca (AZN) Published first on TheFly – the ultimate source for real-time,...
Abivax (ABVX) has granted AstraZeneca (AZN) an exclusive period through March 23 to access confidential information and formalize a potential takeover offer, La...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The study Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.